Can This Artificial Pancreas Cure Type-1 Diabetes?
Interactive Video
•
Business, Biology, Health Sciences, Life Skills
•
University
•
Practice Problem
•
Hard
Wayground Content
FREE Resource
Beta O2 has developed an implantable device, the Better Air Device, which may offer a cure for type 1 diabetes by using real living cells to produce insulin. Unlike a pancreas transplant, it doesn't require immunosuppressants due to engineered protective mechanisms. The device is implanted in the abdomen and requires daily oxygen injections, a minor procedure compared to daily insulin injections. Currently in phase one trials in Sweden, Beta O2 aims to launch in Europe by 2017-2018 and later in the US. The company has raised $21 million but plans further fundraising to expedite market entry. The device targets a multi-billion dollar market with 17 million type 1 diabetics worldwide.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What is the expected timeline for the Beta O2 device to hit the market?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What is the estimated market size for the Beta O2 device?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
